Scancell (LON:SCLP) Shares Pass Below 200 Day Moving Average – Here’s What Happened

Scancell Holdings plc (LON:SCLPGet Free Report)’s share price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 13.34 ($0.17) and traded as low as GBX 8.84 ($0.11). Scancell shares last traded at GBX 8.84 ($0.11), with a volume of 979,057 shares.

Scancell Stock Performance

The firm has a market cap of £91.60 million, a price-to-earnings ratio of -13.56 and a beta of 0.35. The stock’s fifty day moving average is GBX 10.07 and its two-hundred day moving average is GBX 13.32. The company has a debt-to-equity ratio of -566.79, a quick ratio of 13.01 and a current ratio of 3.42.

Scancell (LON:SCLPGet Free Report) last released its quarterly earnings results on Thursday, January 30th. The company reported GBX (1.35) (($0.02)) earnings per share for the quarter. On average, analysts expect that Scancell Holdings plc will post -2.5361112 earnings per share for the current fiscal year.

About Scancell

(Get Free Report)

Scancell (LSE:SCLP) is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers.

Scancell has developed a pipeline of ‘off-the-shelf’ vaccines to induce immune responses and highly tumour specific monoclonal antibodies to redirect immune cells or drugs.

Recommended Stories

Receive News & Ratings for Scancell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scancell and related companies with MarketBeat.com's FREE daily email newsletter.